NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the

IGHV mutation NOTCH1 activation NOTCH1 mutation chronic lymphocytic leukemia risk stratification

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2021
Historique:
received: 16 02 2021
accepted: 04 05 2021
entrez: 14 6 2021
pubmed: 15 6 2021
medline: 15 6 2021
Statut: epublish

Résumé

NOTCH1 mutations and deregulated signal have been commonly found in chronic lymphocytic leukemia (CLL) patients. Whereas the impact of

Identifiants

pubmed: 34123837
doi: 10.3389/fonc.2021.668573
pmc: PMC8187905
doi:

Types de publication

Journal Article

Langues

eng

Pagination

668573

Informations de copyright

Copyright © 2021 Baldoni, Del Papa, De Falco, Dorillo, Sorrentino, Rompietti, Adamo, Nogarotto, Cecchini, Mondani, Silva Barcelos, Moretti, Mameli, Fabi, Sorcini, Stella, Giancola, Guardalupi, Ulbar, Plebani, Guarente, Rosati, Di Nicola, Marchioni, Di Ianni and Sportoletti.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Cancer. 2018 Aug 15;143(4):958-970
pubmed: 29508386
Blood. 2021 Feb 4;137(5):646-660
pubmed: 33538798
Blood. 2012 Jan 12;119(2):521-9
pubmed: 22077063
Br J Haematol. 2009 Sep;146(6):689-91
pubmed: 19604236
Leukemia. 2020 Feb;34(2):462-477
pubmed: 31467429
Oncotarget. 2016 Dec 27;7(52):86469-86479
pubmed: 27835908
Int J Cancer. 2013 Apr 15;132(8):1940-53
pubmed: 23001755
Oncotarget. 2015 Jun 30;6(18):16559-72
pubmed: 26041884
Leukemia. 2014 Feb;28(2):436-9
pubmed: 24177259
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):E2911-E2919
pubmed: 28314854
Clin Cancer Res. 2019 Dec 15;25(24):7540-7553
pubmed: 31578228
Cell Death Dis. 2018 Nov 26;9(12):1160
pubmed: 30478302
Leukemia. 2014 May;28(5):1060-70
pubmed: 24170027
Blood. 2009 Jan 22;113(4):856-65
pubmed: 18796623

Auteurs

Stefano Baldoni (S)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Department of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.

Beatrice Del Papa (B)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Filomena De Falco (F)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Erica Dorillo (E)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Carlo Sorrentino (C)

Department of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.

Chiara Rompietti (C)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Francesco Maria Adamo (FM)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Manuel Nogarotto (M)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Debora Cecchini (D)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Elena Mondani (E)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Estevao Carlos Silva Barcelos (EC)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Department of Biological Sciences, Postgraduate Program in Biotechnology (UFES), Federal University of Espirito Santo, Vitoria, Brazil.

Lorenzo Moretti (L)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Maria Grazia Mameli (MG)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Bianca Fabi (B)

Department of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.

Daniele Sorcini (D)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Arianna Stella (A)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Raffaella Giancola (R)

Department of Oncology and Hematology, "Santo Spirito" Hospital, Pescara, Italy.

Francesco Guardalupi (F)

Department of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.

Francesca Ulbar (F)

Department of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.

Sara Plebani (S)

Hematology Unit, "San Salvatore" Hospital, L'Aquila, Italy.

Valerio Guarente (V)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Emanuela Rosati (E)

Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Marta Di Nicola (M)

Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.

Michele Marchioni (M)

Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.

Mauro Di Ianni (M)

Department of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Department of Oncology and Hematology, "Santo Spirito" Hospital, Pescara, Italy.

Paolo Sportoletti (P)

Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Classifications MeSH